Navigation Links
Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
Date:12/2/2010

BETHESDA, Md., Dec. 2, 2010 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

The first post hoc analysis done of the Biospherics Phase 3 NEET clinical trial suggests that the larger reduction in HbA1c observed in the Per Protocol population in the USA may be the result of D-tagatose acting at the level of metabolic control mediated by adipocytes (fat cells). In other words, in patients with sufficient numbers and size of adipocytes for dietary carbohydrate effects to be manifested, there is a role for adipocytes in the mechanism of D-tagatose in the control of blood glucose and plasma triglyceride levels.

"Tagatose appears to be more effective in Type 2 diabetes patients with adipocyte dysfunction that no longer permits the adipocytes to act appropriately as an endocrine organ controlling HbA1c," said Dr. Robert Lodder, President of Spherix.

Results from the first post hoc analysis of the Biospherics Phase 3 70971-004 clinical trial showed a correlation between HbA1c and BMI through all of the monthly visits (v1-v14) in the trial (see Table 1). Results of the Phase 3 trial, as previously reported, showed a greater lowering of HbA1c with tagatose treatment in patients from the US cohort (-1.1 vs. placebo at 10 months of therapy in the Per Protocol population) compared with India (-0.2 vs. placeb
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Spherix D-tagatose to be Supplied by Inalco SpA
4. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
5. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
6. Spherix Elects New Independent Director, and Elects Chairman of the Board
7. Spherix Reports First Quarter 2009 Earnings
8. Spherix Announces Positive Phase 2 Study Results
9. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
10. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
11. Spherix Reports Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... Like ... enlargement techniques have also been advanced, upgraded, made more effective and less intrusive and ... of Loria Medical Penile Enlargement Center. Dr. Loria currently stands as the only ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased ... until a heart rate of 150 beats versus 100 beats, this is a big ... able to give life back to patients with heart disease," he adds. People with ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... a blog post that encourages the understanding and treatment of ankle sprains. A ... for in-home remedies. This can be dangerous if the condition augments and causes ...
(Date:7/31/2015)... ... July 31, 2015 , ... Awarded to only the Top 10 hair ... that they are the latest recipients of the Center of Clinical Excellence for ... the worldwide leaders in the science of hair transplant. , Parsa Mohebi Hair Restoration ...
(Date:7/31/2015)... Detroit, MI (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable ... The U.S. Women's National Soccer Team will face the Australia Women's National Team in conjunction ... by a score of 5-2. Carli Lloyd from the USA team was awarded the ...
Breaking Medicine News(10 mins):Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... , Got Moving Stories? Calling all Reporters, Writers, ... Aug. 5 The American Academy of Orthopaedic Surgeons ... MORE Awards . These awards recognize excellence in ... of bones, joints and muscles. The AAOS invites all journalists to ...
... , , CINCINNATI, Aug. ... (Nasdaq: STRM ) today announced that, in an effort ... have an independent, non-management director as the Company,s Chairman of the ... Phillips, a current independent member of the Company,s Board of Directors, ...
... ... Jacobson & Han LLP, internationally recognized immigration attorneys, offers on-site ... immigration worksite enforcement and new federal mandates. The current immigration ... need to become aware of how these challenges affect their business ...
... , , , , ... for the Prevention and Treatment of Cancer-Related Infections to include ... The NCCN Guidelines provide specific recommendations on the prevention, diagnosis, ... afflict patients with cancer , , FORT ...
... , , , ... S.C., and Carolinas HealthCare System (CHS) have executed an Affiliation Services ... Executives in attendance included CHS President and Chief Operating Officer Joe ... Officer John Miller. , , The ...
... , , , ... Effient(TM) (prasugrel), a new antiplatelet medicine, is now available in pharmacies ... Company (NYSE: LLY ) announced today. , ... Effient tablets on July 10 for the reduction of thrombotic cardiovascular ...
Cached Medicine News:Health News:MORE (Media Orthopaedic Reporting Excellence) Awards Call for Entries is Now Open 2Health News:MORE (Media Orthopaedic Reporting Excellence) Awards Call for Entries is Now Open 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 2Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 4Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 5Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 2Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 3Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 4Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 5Health News:NCCN Updates Infection Guidelines to Include Information About H1N1 Virus (Swine Flu) 2Health News:NCCN Updates Infection Guidelines to Include Information About H1N1 Virus (Swine Flu) 3Health News:South Carolina-Based AnMed Health Selects CHS for Affiliation Agreement 2Health News:South Carolina-Based AnMed Health Selects CHS for Affiliation Agreement 3Health News:Effient(TM) is Now Available in Pharmacies 2Health News:Effient(TM) is Now Available in Pharmacies 3Health News:Effient(TM) is Now Available in Pharmacies 4
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3...
... With membrane parasite ... and cytoplasm as antigen. ... different antigens than the ... possible to use two ...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
Silicone ICD lead...
Medicine Products: